G Protein-Coupled receptors and heterotrimeric G proteins as cancer drivers

FEBS Letters

article

Nadia Arang¹  J. Silvio Gutkind¹ 

[1] Department of Pharmacology, Moores Cancer Center, University of California

关键词: angiogenesis;    cancer;    cancer metabolism;    G protein-coupled receptors;    GTPases;    immune therapy;    inflammation;    metastasis;    precision medicine;    signal transduction;   

DOI  :  10.1002/1873-3468.14017

来源: John Wiley & Sons Ltd.

【 摘 要 】

G protein-coupled receptors (GPCRs) and heterotrimeric G proteins play central roles in a diverse array of cellular processes. As such, dysregulation of GPCRs and their coupled heterotrimeric G proteins can dramatically alter the signalling landscape and functional state of a cell. Consistent with their fundamental physiological functions, GPCRs and their effector heterotrimeric G proteins are implicated in some of the most prevalent human diseases, including a complex disease such as cancer that causes significant morbidity and mortality worldwide. GPCR/G protein-mediated signalling impacts oncogenesis at multiple levels by regulating tumour angiogenesis, immune evasion, metastasis, and drug resistance. Here, we summarize the growing body of research on GPCRs and their effector heterotrimeric G proteins as drivers of cancer initiation and progression, and as emerging antitumoural therapeutic targets.

【 授权许可】

Unknown